Related Experiment Video
Updated: May 12, 2026
05:50
Ameliorating Osteoarthritis in Mice Using Silver Nanoparticles
Published on: June 2, 2023
New horizons in osteoarthritis.
Claire Y J Wenham1, Philip G Conaghan
1Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Chapel Allerton Hospital, Leeds, UK. c.y.j.wenham@leeds.ac.uk
Age and Ageing
|April 10, 2013
Summary
Osteoarthritis (OA) is a prevalent joint disease causing pain and disability. Emerging research suggests targeting subchondral bone may offer the first structure-modifying treatments for OA, moving beyond symptom management.
Area of Science:
- Rheumatology and Orthopedics
- Medical Imaging and Diagnostics
Background:
- Osteoarthritis (OA) is the most common global arthritis, increasing with aging populations and causing significant pain, disability, and economic burden.
- Modern imaging, particularly MRI, reveals OA as a dynamic joint remodeling process involving all joint structures.
- Inflammation (synovitis) and subchondral bone changes are common in OA, frequently associated with joint pain and disease progression.
Purpose of the Study:
- To explore novel therapeutic strategies for osteoarthritis by targeting specific pathologies.
- To investigate the potential for structure modification in OA treatment, moving beyond traditional symptom management.
- To highlight recent advancements in understanding OA pathology and pain pathways for developing new analgesic options.
Main Methods:
- Utilizing advanced imaging techniques, specifically Magnetic Resonance Imaging (MRI), to assess joint structures and pathologies in OA.
- Reviewing recent clinical trials investigating novel therapeutic agents targeting specific OA pathways, including nerve growth factor, central pain mechanisms, and bradykinin receptors.
- Analyzing the association between imaging-detected pathologies (synovitis, subchondral bone changes) and clinical outcomes like joint pain and structural progression.
Main Results:
- MRI demonstrates that OA involves dynamic remodeling of all joint structures, with synovitis and subchondral bone changes being common and linked to pain.
- Current OA treatments primarily focus on symptom management and are often limited by side effects or efficacy.
- Recent trials indicate potential for structure modification therapies, particularly those targeting the subchondral bone.
Conclusions:
- Targeting specific OA pathologies, such as inflammation and subchondral bone changes, offers promising new therapeutic avenues.
- Novel analgesic approaches, including monoclonal antibodies and centrally acting drugs, are emerging for OA pain management.
- For the first time, evidence suggests that treating the subchondral bone may enable structure modification in osteoarthritis, representing a significant shift in treatment paradigms.
Related Concept Videos
01:31Osteoclasts in Bone Remodeling
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
01:27Degenerative Disc Disease I: Introduction
Degenerative disc disease is a chronic condition in which intervertebral discs gradually lose structure and function. It is not infectious or autoimmune; rather, it results from age-related biochemical and mechanical changes, influenced by genetic, metabolic, and environmental factors.Structure and Function of DiscsThe spine contains 23 intervertebral discs that absorb load, distribute forces, maintain spacing, and allow flexibility. Each disc consists of a nucleus pulposus, a gel-like core...
01:23Degenerative Disc Disease ll: Pathophysiology
The symptoms of degenerative disc disease arise from a combination of mechanical compression, vascular compromise, and biochemical inflammation, which together disrupt nerve function and produce pain.Mechanical CompressionDisc degeneration reduces height and elasticity, predisposing to herniation of the nucleus pulposus, a major cause of radicular pain. Herniations may be protrusion (bulging with intact annulus), extrusion (nucleus extends beyond disc but remains connected), or sequestration...